Charles River Laboratories International (CRL) News Today $233.47 +11.66 (+5.26%) (As of 07/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period July 26 at 10:20 AM | marketbeat.comNatixis Purchases New Position in Charles River Laboratories International, Inc. (NYSE:CRL)Natixis acquired a new position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 3,905 shares of the medical research company's stock, valuJuly 25 at 11:49 AM | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Position Boosted by Bessemer Group Inc.Bessemer Group Inc. raised its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 456.6% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor ownedJuly 25 at 3:23 AM | americanbankingnews.comCharles River Laboratories International, Inc. (NYSE:CRL) Receives $252.29 Consensus Target Price from BrokeragesJuly 24 at 7:31 PM | marketbeat.comUniSuper Management Pty Ltd Has $1.09 Million Stock Position in Charles River Laboratories International, Inc. (NYSE:CRL)UniSuper Management Pty Ltd increased its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 452.1% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,003 shares of the meJuly 24 at 10:07 AM | finance.yahoo.comCharles River Laboratories and Autobahn Labs Announce Collaborative Program to Accelerate Academic Drug DiscoveryJuly 22, 2024 | marketbeat.comVanguard Group Inc. Has $1.64 Billion Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)Vanguard Group Inc. increased its holdings in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 1.1% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,046,467 shJuly 22, 2024 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Given Consensus Rating of "Moderate Buy" by BrokeragesCharles River Laboratories International, Inc. (NYSE:CRL - Get Free Report) has received an average recommendation of "Moderate Buy" from the fourteen brokerages that are presently covering the firm, MarketBeat reports. Seven analysts have rated the stock with a hold recommendation and seven have iJuly 20, 2024 | marketbeat.comRussell Investments Group Ltd. Purchases 8,959 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Russell Investments Group Ltd. boosted its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 31.9% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 37,074 shares of the medical researJuly 19, 2024 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Shares Acquired by Mitsubishi UFJ Asset Management Co. Ltd.Mitsubishi UFJ Asset Management Co. Ltd. raised its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 27.7% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 63,1July 18, 2024 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Stock Holdings Lessened by BNP PARIBAS ASSET MANAGEMENT Holding S.A.BNP PARIBAS ASSET MANAGEMENT Holding S.A. reduced its holdings in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 19.9% during the first quarter, according to the company in its most recent filing with the SEC. The fund owned 204,044 shares of the medical research companyJuly 18, 2024 | marketbeat.comEntropy Technologies LP Sells 2,518 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Entropy Technologies LP trimmed its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 42.6% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,390 shares of the medical reseJuly 16, 2024 | marketbeat.comQsemble Capital Management LP Makes New $995,000 Investment in Charles River Laboratories International, Inc. (NYSE:CRL)Qsemble Capital Management LP bought a new position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 3,672 shares of tJuly 16, 2024 | globenewswire.comCRL INVESTIGATION ALERT: Johnson Fistel LLP Investigates Charles River Laboratories' Directors and Officers for Breach of Fiduciary DutiesJuly 15, 2024 | marketbeat.comMontag A & Associates Inc. Buys Shares of 8,221 Charles River Laboratories International, Inc. (NYSE:CRL)Montag A & Associates Inc. purchased a new position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 8,2July 13, 2024 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Stock Position Increased by TimesSquare Capital Management LLCTimesSquare Capital Management LLC increased its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 324.1% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owneJuly 9, 2024 | marketbeat.comBNP Paribas Financial Markets Purchases 20,941 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)BNP Paribas Financial Markets increased its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 45.3% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 67,148 shares of the medical research company's stock after buying an addJuly 5, 2024 | benzinga.comCharles River Could be an Apt Pick Right Now: Here's WhyJuly 5, 2024 | marketbeat.comNorden Group LLC Raises Stake in Charles River Laboratories International, Inc. (NYSE:CRL)Norden Group LLC boosted its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 2,642.3% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 31,399 shares of the medical reJune 28, 2024 | marketbeat.comCharles River Laboratories International (NYSE:CRL) Now Covered by BarclaysBarclays initiated coverage on shares of Charles River Laboratories International in a report on Friday. They issued an "equal weight" rating and a $230.00 price objective on the stock.June 28, 2024 | marketbeat.comCharles River Laboratories International's (CRL) Hold Rating Reiterated at ArgusArgus reissued a "hold" rating on shares of Charles River Laboratories International in a research note on Friday.June 27, 2024 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Receives Average Rating of "Moderate Buy" from AnalystsShares of Charles River Laboratories International, Inc. (NYSE:CRL - Get Free Report) have been given a consensus rating of "Moderate Buy" by the thirteen ratings firms that are presently covering the company, Marketbeat.com reports. Five equities research analysts have rated the stock with a holdJune 25, 2024 | businesswire.comCharles River Laboratories Announces Strategic Lentiviral Vector Manufacturing Collaboration with Gates Institute at University of Colorado Anschutz Medical CampusJune 24, 2024 | marketbeat.comGlobal Assets Advisory LLC Makes New $8.30 Million Investment in Charles River Laboratories International, Inc. (NYSE:CRL)Global Assets Advisory LLC acquired a new stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 30,635 shares of the medical research company's stoJune 23, 2024 | marketbeat.comD. Scott Neal Inc. Acquires New Position in Charles River Laboratories International, Inc. (NYSE:CRL)D. Scott Neal Inc. purchased a new stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) in the 1st quarter, according to its most recent filing with the SEC. The fund purchased 32,951 shares of the medical research company's stock, valued at approximately $8,928,000. ChaJune 22, 2024 | marketbeat.comCongress Asset Management Co. MA Reduces Stock Position in Charles River Laboratories International, Inc. (NYSE:CRL)Congress Asset Management Co. MA cut its holdings in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 2.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 453,392 shares of the medical rJune 20, 2024 | marketbeat.comVanguard Group Inc. Acquires 26,446 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Vanguard Group Inc. lifted its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 0.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 5,980,306 shares of the medical resJune 18, 2024 | marketbeat.comConfluence Investment Management LLC Takes Position in Charles River Laboratories International, Inc. (NYSE:CRL)Confluence Investment Management LLC purchased a new stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) during the first quarter, according to its most recent filing with the SEC. The firm purchased 96,957 shares of the medical research company's stock, valued at approJune 17, 2024 | businesswire.comCharles River and Captain T Cell Announce Plasmid DNA and Viral Vector Manufacturing Alliance for Gene-Modified Cell TherapyJune 15, 2024 | marketbeat.comFIL Ltd Acquires 125,000 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)FIL Ltd lifted its stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 23.2% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 662,650 shares of the medical research company's stock after purJune 14, 2024 | marketbeat.comStockNews.com Downgrades Charles River Laboratories International (NYSE:CRL) to HoldStockNews.com lowered shares of Charles River Laboratories International from a "buy" rating to a "hold" rating in a research note on Friday.June 12, 2024 | marketbeat.comArgent Capital Management LLC Sells 93,821 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Argent Capital Management LLC reduced its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 60.2% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 61,952 shares of the medical research company's stock after sellinJune 12, 2024 | globenewswire.comCRL INVESTIGATION ALERT: Johnson Fistel LLP Investigates Charles River Laboratories' Directors and Officers for Breach of Fiduciary DutiesJune 11, 2024 | marketbeat.comCibc World Markets Corp Purchases 3,765 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Cibc World Markets Corp boosted its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 133.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 6,595 shares of the medical researchJune 10, 2024 | marketbeat.comBellevue Group AG Has $51.48 Million Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)Bellevue Group AG lessened its stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 5.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 217,756 shares of thJune 8, 2024 | marketbeat.comMorningstar Investment Services LLC Purchases 51,110 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Morningstar Investment Services LLC grew its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 99.2% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 102,626 shares of the mediJune 7, 2024 | marketbeat.comPublic Employees Retirement Association of Colorado Sells 37,050 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Public Employees Retirement Association of Colorado reduced its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 43.9% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund ownedJune 6, 2024 | marketbeat.comCharles River Laboratories International (NYSE:CRL) Upgraded to Buy at StockNews.comStockNews.com upgraded shares of Charles River Laboratories International from a "hold" rating to a "buy" rating in a report on Thursday.June 6, 2024 | globenewswire.comCRL INVESTIGATION ALERT: Johnson Fistel LLP Investigates Charles River Laboratories' Directors and Officers for Breach of Fiduciary DutiesJune 6, 2024 | marketbeat.comArmistice Capital LLC Sells 120,000 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Armistice Capital LLC decreased its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 76.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 36,000 shares of the medical reseaJune 6, 2024 | marketbeat.comCharles River Laboratories International (NYSE:CRL) Now Covered by Analysts at The Goldman Sachs GroupThe Goldman Sachs Group assumed coverage on shares of Charles River Laboratories International in a research report on Thursday. They issued a "buy" rating and a $290.00 target price on the stock.June 6, 2024 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Holdings Raised by Pinebridge Investments L.P.Pinebridge Investments L.P. lifted its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 23.1% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 100,381 shares of the medical research compaJune 4, 2024 | marketbeat.comBell Asset Management Ltd Sells 6,868 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Bell Asset Management Ltd trimmed its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 13.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 43,439 shares of the mediJune 3, 2024 | marketbeat.comNicholas Company Inc. Has $16.71 Million Position in Charles River Laboratories International, Inc. (NYSE:CRL)Nicholas Company Inc. increased its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 17.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 70,681 shares of the medical reseJune 3, 2024 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Position Increased by Meritage Group LPMeritage Group LP boosted its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 30.8% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 1,155,376 shares of the medical reJune 2, 2024 | marketbeat.comShort Interest in Charles River Laboratories International, Inc. (NYSE:CRL) Drops By 8.4%Charles River Laboratories International, Inc. (NYSE:CRL - Get Free Report) was the recipient of a significant drop in short interest during the month of May. As of May 15th, there was short interest totalling 1,740,000 shares, a drop of 8.4% from the April 30th total of 1,900,000 shares. Based on an average trading volume of 516,900 shares, the short-interest ratio is presently 3.4 days.June 2, 2024 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Given Consensus Rating of "Moderate Buy" by AnalystsShares of Charles River Laboratories International, Inc. (NYSE:CRL - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the eleven ratings firms that are presently covering the stock, Marketbeat.com reports. Four analysts have rated the stock with a hold recommendaMay 31, 2024 | marketbeat.comBrokers Set Expectations for Charles River Laboratories International, Inc.'s Q2 2024 Earnings (NYSE:CRL)Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) - Equities research analysts at Zacks Research reduced their Q2 2024 EPS estimates for shares of Charles River Laboratories International in a research note issued to investors on Thursday, May 30th. Zacks Research analyst R.May 31, 2024 | seekingalpha.comCharles River Laboratories: Fair Valuation Against FundamentalsMay 30, 2024 | businesswire.comCharles River Launches Viral Vector Tech Transfer Program to Safeguard Gene Therapy DevelopmentMay 30, 2024 | marketbeat.comCharles River Laboratories International Q1 Earnings Transcript Get Charles River Laboratories International News Delivered to You Automatically Sign up to receive the latest news and ratings for CRL and its competitors with MarketBeat's FREE daily newsletter. Email Address Nvidia insiders dumping shares (Ad)All the signs show the AI market is about to reverse. And unless you know what’s really going on in this sector, you could be wiped out. Inside this new expose, you'll discover exactly how the AI crisis will unfold... how you can prepare for it before it's too late... and how you can potentially profit from it, too. Click here to read the new expose, The Big AI Die-Up while you still can. To see Porter Stansberry's new AI prediction go here now. CRL Media Mentions By Week CRL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRL News Sentiment▼1.060.61▲Average Medical News Sentiment CRL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRL Articles This Week▼86▲CRL Articles Average Week Get Charles River Laboratories International News Delivered to You Automatically Sign up to receive the latest news and ratings for CRL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Agilent Technologies News Mettler-Toledo International News Illumina News Waters News Bio-Techne News Bruker News Bio-Rad Laboratories News Pacific Biosciences of California News Harvard Bioscience News Thermo Fisher Scientific News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:CRL) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredFormer Hedge Fund Manager Issues Crash PredictionOur No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Charles River Laboratories International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Charles River Laboratories International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
